95 related articles for article (PubMed ID: 12655097)
1. The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency.
Thomas C; Dankesreiter A; Wolf H; Schwarzmann F
J Gen Virol; 2003 Apr; 84(Pt 4):959-964. PubMed ID: 12655097
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
3. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.
Schwarzmann F; Prang N; Reichelt B; Rinkes B; Haist S; Marschall M; Wolf H
J Gen Virol; 1994 Aug; 75 ( Pt 8)():1999-2006. PubMed ID: 8046403
[TBL] [Abstract][Full Text] [Related]
4. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
Sun CC; Thorley-Lawson DA
J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
[TBL] [Abstract][Full Text] [Related]
5. ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Perrigoue JG; Mertz JE
J Virol; 2003 Jan; 77(1):199-207. PubMed ID: 12477825
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
7. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
[TBL] [Abstract][Full Text] [Related]
8. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
Ellis AL; Wang Z; Yu X; Mertz JE
J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.
Ruf IK; Rawlins DR
J Virol; 1995 Dec; 69(12):7648-57. PubMed ID: 7494273
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
Schaefer BC; Paulson E; Strominger JL; Speck SH
Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
[TBL] [Abstract][Full Text] [Related]
12. YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter.
Montalvo EA; Cottam M; Hill S; Wang YJ
J Virol; 1995 Jul; 69(7):4158-65. PubMed ID: 7769675
[TBL] [Abstract][Full Text] [Related]
13. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
Schepers A; Pich D; Hammerschmidt W
Virology; 1996 Jun; 220(2):367-76. PubMed ID: 8661388
[TBL] [Abstract][Full Text] [Related]
14. Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells.
MacCallum P; Karimi L; Nicholson LJ
J Gen Virol; 1999 Jun; 80 ( Pt 6)():1501-1512. PubMed ID: 10374969
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication.
Chatila T; Ho N; Liu P; Liu S; Mosialos G; Kieff E; Speck SH
J Virol; 1997 Sep; 71(9):6560-7. PubMed ID: 9261377
[TBL] [Abstract][Full Text] [Related]
16. Histone acetylation and reactivation of Epstein-Barr virus from latency.
Jenkins PJ; Binné UK; Farrell PJ
J Virol; 2000 Jan; 74(2):710-20. PubMed ID: 10623733
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.
Nakayama S; Murata T; Murayama K; Yasui Y; Sato Y; Kudoh A; Iwahori S; Isomura H; Kanda T; Tsurumi T
J Biol Chem; 2009 Aug; 284(32):21557-68. PubMed ID: 19491105
[TBL] [Abstract][Full Text] [Related]
18. A splice variant of E2-2 basic helix-loop-helix protein represses the brain-specific fibroblast growth factor 1 promoter through the binding to an imperfect E-box.
Liu Y; Ray SK; Yang XQ; Luntz-Leybman V; Chiu IM
J Biol Chem; 1998 Jul; 273(30):19269-76. PubMed ID: 9668116
[TBL] [Abstract][Full Text] [Related]
19. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.
Furnari FB; Zacny V; Quinlivan EB; Kenney S; Pagano JS
J Virol; 1994 Mar; 68(3):1827-36. PubMed ID: 8107245
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
